121 related articles for article (PubMed ID: 18769784)
1. [Presence of metallo beta-lactamases in imipenem-resistant Pseudomonas aeruginosa].
Pérez I A; García C P; Poggi M H; Braun J S; Castillo V C; Román JC; Lagos M; Romeo O E; Porte T L; Labarca L J; González R G
Rev Med Chil; 2008 Apr; 136(4):423-32. PubMed ID: 18769784
[TBL] [Abstract][Full Text] [Related]
2. Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital.
Franco MR; Caiaffa-Filho HH; Burattini MN; Rossi F
Clinics (Sao Paulo); 2010; 65(9):825-9. PubMed ID: 21049207
[TBL] [Abstract][Full Text] [Related]
3. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
Martins AF; Zavascki AP; Gaspareto PB; Barth AL
Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
[TBL] [Abstract][Full Text] [Related]
4. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
[TBL] [Abstract][Full Text] [Related]
5. Metallo-beta-lactamase-producing imipenem-resistant Pseudomonas aeruginosa clinical isolates in a university teaching hospital in Malaysia: detection of IMP-7 and first identification of IMP-4, VIM-2, and VIM-11.
Khosravi Y; Tee Tay S; Vadivelu J
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):294-6. PubMed ID: 20462725
[TBL] [Abstract][Full Text] [Related]
6. Resistance Pattern and Detection of Metallo-beta-lactamase Genes in Clinical Isolates of
Zubair KO; Iregbu KC
Niger J Clin Pract; 2018 Feb; 21(2):176-182. PubMed ID: 29465051
[TBL] [Abstract][Full Text] [Related]
7. Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit.
Hammami S; Boutiba-Ben Boubaker I; Ghozzi R; Saidani M; Amine S; Ben Redjeb S
Diagn Pathol; 2011 Oct; 6():106. PubMed ID: 22035284
[TBL] [Abstract][Full Text] [Related]
8. First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes.
Van der Bij AK; Van Mansfeld R; Peirano G; Goessens WH; Severin JA; Pitout JD; Willems R; Van Westreenen M
Int J Antimicrob Agents; 2011 Jun; 37(6):513-8. PubMed ID: 21497065
[TBL] [Abstract][Full Text] [Related]
9. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.
Laupland KB; Parkins MD; Church DL; Gregson DB; Louie TJ; Conly JM; Elsayed S; Pitout JD
J Infect Dis; 2005 Nov; 192(9):1606-12. PubMed ID: 16206075
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.
Ozgumus OB; Caylan R; Tosun I; Sandalli C; Aydin K; Koksal I
Microb Drug Resist; 2007; 13(3):191-8. PubMed ID: 17949306
[TBL] [Abstract][Full Text] [Related]
11. Detection and characterization of metallo beta lactamases producing Pseudomonas aeruginosa.
Manoharan A; Chatterjee S; Mathai D;
Indian J Med Microbiol; 2010; 28(3):241-4. PubMed ID: 20644314
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of imipenem-resistant Pseudomonas aeruginosa in Hiroshima, Japan.
Ohara M; Kouda S; Onodera M; Fujiue Y; Sasaki M; Kohara T; Kashiyama S; Hayashida S; Kadono M; Komatsuzawa H; Gotoh N; Usui T; Itaha H; Kuwabara M; Yokoyama T; Sugai M
Microbiol Immunol; 2007; 51(3):271-7. PubMed ID: 17380046
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial infectious potency of imipenem-resistant Pseudomonas aeruginosa isolated from obstetric and gynecologic infections.
Yin XH; Mikamo H; Tamaya T
J Infect Chemother; 2003 Mar; 9(1):97-100. PubMed ID: 12673417
[TBL] [Abstract][Full Text] [Related]
14. IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital.
Sader HS; Reis AO; Silbert S; Gales AC
Clin Microbiol Infect; 2005 Jan; 11(1):73-6. PubMed ID: 15649310
[TBL] [Abstract][Full Text] [Related]
15. Increasing prevalence of imipenem-resistant Pseudomonas aeruginosa and molecular typing of metallo-beta-lactamase producers in a Korean hospital.
Kim IS; Lee NY; Ki CS; Oh WS; Peck KR; Song JH
Microb Drug Resist; 2005; 11(4):355-9. PubMed ID: 16359195
[TBL] [Abstract][Full Text] [Related]
16. VIM-2 beta-lactamase in Pseudomonas aeruginosa isolates from Zagreb, Croatia.
Bosnjak Z; Bedenić B; Mazzariol A; Jarza-Davila N; Suto S; Kalenić S
Scand J Infect Dis; 2010 Mar; 42(3):193-7. PubMed ID: 20001226
[TBL] [Abstract][Full Text] [Related]
17. Detection of vim- and ipm-type metallo-beta-lactamases in Pseudomonas aeruginosa clinical isolates.
Sepehriseresht S; Boroumand MA; Pourgholi L; Sotoudeh Anvari M; Habibi E; Sattarzadeh Tabrizi M
Arch Iran Med; 2012 Nov; 15(11):670-3. PubMed ID: 23102242
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
[TBL] [Abstract][Full Text] [Related]
19. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
[TBL] [Abstract][Full Text] [Related]
20. Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.
Walsh F; Bracher S; Turner P; Amyes S
Chemotherapy; 2007; 53(6):407-9. PubMed ID: 17934261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
